Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TSX-002 PK in Hypogonadal Males
NCT02222558Phase 2Completed
- Sponsor
- TesoRx Pharma
- Start
- Sep 2014
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of TSX-002 in Hypogonadism (6 arms), sponsored by TesoRx Pharma. Primary endpoint: Percentage of Responders. Started Sep 2014; status: completed.
02
Drugs
TSX-002
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT02222558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02222558.